Skip to main navigation
  • News
  • Alerts
  • Careers
  • Contact
Cidara Therapeutics, Inc.Cidara Therapeutics, Inc.
  • About
    • About Cidara
    • Management Team
    • Board of Directors
    • Partnership Inquiries
    • Careers
  • Pipeline
  • Rezafungin
    • Overview
    • Treatment
    • Prophylaxis
  • Cloudbreak
    • Overview
    • Antiviral
    • Antibacterial
  • Publications
    • Rezafungin for IFIs
    • Rezafungin – Other
    • Cloudbreak
  • Investors

    Secondary Investor Relations

    • Overview
    • Financials
    • Stock Information
    • Corporate Governance
    • News Releases
    • Events and Presentations
    • Analyst Coverage
    • Shareholder Services
Press enter to begin your search
  • Home
  • About
  • Drug Candidates
    • Pipeline
    • CD101 IV
    • CD101 Topical
    • C001
    • Publications
  • Cloudbreak
  • Opportunity
    • Systemic Fungal Infections
    • Systemic Candida Infections
    • Recurrent Vulvovaginal Candidiasis
    • Invasive Aspergillosis
  • Investors

    Secondary Investor Relations

    • Overview
    • Financials
    • Stock Information
    • Corporate Governance
    • News Releases
    • Events and Presentations
    • Analyst Coverage
    • Shareholder Services
  • Contact

Past Events

Past Events

Cidara Therapeutics, Inc. at Ladenburg Thalmann 2018 Healthcare Conference
 Tuesday, 10/02/18 at 8:30 AM EDT

Cidara Therapeutics, Inc. at Cantor Fitzgerald Global Healthcare Conference
 Monday, 10/01/18 at 9:30 AM EDT

STRIVE Part A Phase 2 Topline Results
 Monday, 03/19/18 at 8:00 AM EDT
Supporting Materials
STRIVE Part A Phase 2 Topline Results Presentation 840.5 KB

NAVIGATION

  • Overview
  • Financials
    • SEC Filings
  • Stock Information
    • Stock Quote & Chart
    • Historical Lookup
    • Investment Calculator
  • Corporate Governance
    • Highlights
    • Management Team
    • Board of Directors
    • Committee Composition
  • News Releases
  • Events and Presentations
    • Event Calendar
    • Past Events
  • Analyst Coverage
  • Shareholder Services
    • Investor FAQs
    • Information Request
    • E-mail Alerts
    • Investor Contact

Tool Kit

Print Page Print Page
RSS Feeds RSS Feeds
E-mail Alerts E-mail Alerts
Get Important News and Updates by Email Subscribe

About Cidara

Cidara is a clinical-stage biotechnology company focused on developing new anti-infectives and immunotherapies that have the potential to transform the standard of care and save or improve patients' lives.
Learn more >>

Recent News

Cidara Therapeutics to Present New Data on Rezafungin and its Cloudbreak Antiviral Candidate for Influenza at ASM Microbe 2019
June 5, 2019
Cidara Provides Corporate Update and Reports First Quarter 2019 Financial Results
May 9, 2019
Cidara Therapeutics Highlights New Data from Multiple Rezafungin Studies Presented at ECCMID 2019
April 16, 2019

Navigation

Secondary Investor Relations

  • Overview
  • Financials
  • Stock Information
  • Corporate Governance
  • News Releases
  • Events and Presentations
  • Analyst Coverage
  • Shareholder Services

Contact Us

Cidara Therapeutics, Inc.
6310 Nancy Ridge Drive, Suite 101
San Diego, CA 92121
Tel: (858) 752-6170
Email: info@cidara.com

© 2019 Cidara Therapeutics, Inc. | Terms of Use | Privacy Policy

Quick Links

Secondary Investor Relations

  • Overview
  • Financials
  • Stock Information
  • Corporate Governance
  • News Releases
  • Events and Presentations
  • Analyst Coverage
  • Shareholder Services

Tweets by @CidaraThera